Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
This systematic review evaluated the feasibility of using digital phenotyping—extracting mental health markers from smartphone and device interactions—to predict symptom relapse or exacerbation in mental health patients. Analysis of 29 peer-reviewed studies found digital phenotyping applied primarily to schizophrenia, mood disorders, and anxiety disorders, offering potential for remote mental health monitoring.
This retrospective cohort study examined antidepressant prescribing patterns in 131 transgender and nonbinary adults diagnosed with gender dysphoria and concurrent mood or anxiety disorders between 2005-2021. Key findings include no significant difference in overall antidepressant prescriptions across gender identities at diagnosis, higher bupropion use in transgender females, and that 38% of patients lacked active antidepressants despite mood/anxiety diagnoses.
This study evaluated the reliability and validity of the GAD-7 anxiety screening tool in 278 postpartum Polish mothers, finding excellent internal consistency (Cronbach's Alpha = 0.90) and strong correlations with depression and stress measures. Confirmatory factor analysis confirmed the questionnaire's structural validity and suitability for assessing postpartum anxiety in this population.
This study compared emotional experiences of 88 participants (44 with social anxiety disorder, 44 without) over 21 days using daily experience sampling. Individuals with SAD reported higher anger levels, particularly during interactions with distant others, and showed a unique pattern where daily anger predicted increased anxiety the following day, suggesting anger may maintain anxiety symptoms in SAD.
This open-label pilot study examined the feasibility of intensive 4-day cognitive behavior therapy for social anxiety disorder in 30 patients, using validated outcome measures including the Liebowitz Social Anxiety Scale, GAD-7, and PHQ-9. Results showed large effect sizes for social anxiety symptoms and secondary improvements in generalized anxiety and depression, with 55% remission and 90% treatment response rates at 3-month follow-up.